Area of research
Hematology · Speech and Hearing
Research interest
Research focused on Immunology and Disease, with related work in Juvenile, Immunodeficiency, Prednisone. Notable publications include 'Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency', 'Detection of interferon alpha protein reveals differential levels and cellular sources in disease', and 'Treating juvenile idiopathic arthritis to target: recommendations of an international task force'.
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis
The EULAR points to consider regarding the development of criteria for the assessment of the disease activity in adult-onset Still’s disease
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
Individuals with <i>JAK1</i> variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis
Helper T cell immunity in humans with inherited CD4 deficiency
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.
PubMed 2018cited by 60position: middle
The European network for care of children with paediatric rheumatic diseases: care across borders
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
THU0641 The disease burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international health related quality of life survey and retrospective chart review
The Impact Of Systemic Juvenile Idiopathic Arthritis (SJIA) On A Caregiver’s Productivity And The Child’s Schooling
Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver’s Perspective
Compliance And Treatment Satisfaction With Biological Treatments For Systemic Juvenile Idiopathic Arthritis (SJIA)
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Development of the autoinflammatory disease damage index (ADDI)
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind
Brief Report: Childhood‐Onset Systemic Necrotizing Vasculitides: Long‐Term Data From the French Vasculitis Study Group Registry
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency